CCI version 18.1: Get paid separately for administering Provenge®

Why This Topic Matters

CCI updates can change whether services are payable together or separately, affecting reimbursement, claim edits, and resubmission decisions. Understanding the scope of the update helps practices assess which departments or procedure families may be impacted.

Article Sections

1. Overview of CCI 18.1 changes

   Introduces the second-quarter update and summarizes which specialties and service areas are most affected. It also frames the general scope of the changes compared with the prior quarter.

2. Provenge administration and related billing changes

   Discusses update activity involving a prostate cancer drug and associated billing categories. It also notes timing and retroactive context for the edit changes.

3. Intensive cardiac rehabilitation edit changes

   Covers a change affecting a pair of intensive cardiac rehabilitation services and the role of modifier indicators. Medicare policy context is mentioned in relation to reporting limits.

4. New pairs focus on brain, spine, neck

   Summarizes the concentration of new edit pairs in neurosurgery and orthopedic procedure families. The section also highlights broader patterns in the update across major anatomical regions.

5. More notes on new CCI edits

   Reviews additional categories of updated edit pairs across vascular, transplant, imaging, audiology, electromyography, and ophthalmology-related services. It also notes changes affecting mutually exclusive edits and modifier override availability.

6. Modifier changes

   Addresses additional modifier-related update activity tied to deleted or changed edit pairs. The focus is on how the update affects separate billing scenarios at a high level.